Biogenum Receives Million Grant to Enhance Psychosocial Research for DementiaPosted by Donald Hood on December 9th, 2019 (1888 PressRelease) The grant marks the first time the company receives direct funding as principal investigator in a research study. Biogenum (ISIN: KR7013369996), a clinical stage biopharmaceutical company pioneering immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration, is pleased to announce that it has received a million dollar grant from a consortium of investors, to strengthen the current framework for psychosocial research by examining care for people living with dementia and their care partners. “Biogenum is committed to improving care and support for people living with Alzheimer’s and all other types of dementia, as well as their care partners. This research will develop a framework that defines evidence-based measures and encourages utilizing them more consistently to accelerate knowledge, understanding and application of care strategies that improve the quality of life,” said Jack Chin Hoo, Ph.D., Principal Investigator of the study and Senior Director of Quality care and Psychosocial research at Biogenum. “This is an important area of development and our institution welcomes the opportunity to elevate the current state of psychosocial research focused on examining dementia care.” Working with leading dementia care researchers and care support experts, will address the following matters: “The study offers a unique opportunity to usher in a new direction for psychosocial research, examining the care of people living with dementia and their caregivers,” said Choi Jun-seok, Chairman and CEO of Biogenum. “While it’s important to study decline and impairment associated with Alzheimer’s and other dementias, it’s vital that we also work to advance new strategies and interventions that can improve the quality of life throughout the disease continuum for both individuals with dementia and their caregivers.” About Biogenum http://www.biogenum.com Like it? Share it!More by this author |